Newly public Medline spent 2025 telling investors its customer relationship strategy, product conversion model and ability to ...

Medline Inc. (NASDAQ:MDLN) is one of the stocks Jim Cramer shed light on. Cramer discussed the company’s IPO during the episode, as he remarked: “So is Medline worth buying after today’s IPO and the ...

Recent Medline moves include new vendor agreements and an IPO, strengthening supply chain ties with major health systems.

Kentucky-based Signature HealthCare has entered a prime vendor agreement with Medline. The agreement, signed in July 2025, gives Signature HealthCare access to Medline’s full portfolio of ...

The Medline database is one of the key resources that has enabled the development of evidence-based practice. The availability of Medline and other electronic databases, Embase, LILACS, CINHAL and the ...